• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jason L. Hornick, MD, PhD


  • Wojcik JB, Bellizzi AM, Dal Cin P, Bredella MA, Fletcher CD, Hornicek FJ, Deshpande V, Hornick JL, Nielsen GP.Primary Sclerosing Epithelioid Fibrosarcoma of Bone: Analysis of a Series.Am J Surg Pathol. 2014 Jun 11.
  • Demicco EG, Boland GM, Brewer Savannah KJ, Lusby K, Young ED, Ingram D, Watson KL, Bailey M, Guo X, Hornick JL, van de Rijn M, Wang WL, Torres KE, Lev D, Lazar AJ.Progressive Loss Of Myogenic Differentiation In Leiomyosarcoma Has Prognostic Value.Histopathology. 2014 May 30.
  • Baheti AD, Tirumani SH, Shinagare AB, Rosenthal MH, Hornick JL, Ramaiya NH, Wolpin BM.Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.Abdom Imaging. 2014 May 29.
  • Doyle LA, Hornick JL.Pathology of Extramedullary Mastocytosis.Immunol Allergy Clin North Am. 2014 May;34(2):323-339.
  • Wang R, Liu W, Helfer CM, Bradner JE, Hornick JL, Janicki SM, French CA, You J.Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.Cancer Res. 2014 Apr 16.
  • Somarouthu BS, Shinagare AB, Rosenthal MH, Tirumani H, Hornick JL, Ramaiya NH, Tirumani SH.Multimodality Imaging Features, Metastatic Pattern and Clinical Outcome in Adult Extraskeletal Ewing Sarcoma: Experience in 26 Patients.Br J Radiol. 2014 Apr 15:20140123.
  • Vivero M, Doyle LA, Fletcher CD, Mertens F, Hornick JL.GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling.Histopathology. 2014 Jan 23.
  • Stockman DL, Hornick JL, Deavers MT, Lev DC, Lazar AJ, Wang WL.ERG and FLI1 protein expression in epithelioid sarcoma.Mod Pathol. 2014 Apr;27(4):496-501.
  • Gordon RW, Tirumani SH, Kurra V, Shinagare AB, Jagannathan JP, Hornick JL, Ramaiya NH.MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: experience in 47 patients.Skeletal Radiol. 2014 May;43(5):615-22.
  • Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ.Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.Dis Colon Rectum. 2014 Apr;57(4):449-59.
  • Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL.Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics.Mod Pathol. 2014 Mar;27(3):390-5.
  • Jo VY, Hornick JL, Qian X.Utility of brachyury in distinction of chordoma from cytomorphologic mimics in fine-needle aspiration and core needle biopsy.Diagn Cytopathol. 2014 Feb 19.
  • Elias KM, Labidi-Galy SI, Vitonis AF, Hornick JL, Doyle LA, Hirsch MS, Cramer DW, Drapkin R.Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.Gynecol Oncol. 2014 Feb;132(2):328-33.
  • Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X.Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.Cancer Cytopathol. 2014 Feb;122(2):128-37.
  • Abadin SS, Ayala-Ramirez M, Jimenez C, Dickson PV, Liang Y, Lazar AJ, Hornick JL, Cotton M, Sui D, Rich T, Lee JE, Grubbs E, Perrier ND.Impact of surgical resection for subdiaphragmatic paragangliomas.World J Surg. 2014 Mar;38(3):733-41.
  • Yurgelun MB, Hornick JL, Curry VK, Ukaegbu CI, Brown EK, Hiller E, Chittenden A, Goldberg JE, Syngal S.Therapy-Associated Polyposis as a Late Sequela of Cancer Treatment.Clin Gastroenterol Hepatol. 2013 Dec 19.
  • Tirumani SH, Shinagare AB, Hargreaves J, Jagannathan JP, Hornick JL, Wagner AJ, Ramaiya NH.Imaging features of primary and metastatic malignant perivascular epithelioid cell tumors.AJR Am J Roentgenol. 2014 Feb;202(2):252-8.
  • Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP.Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.J Am Coll Surg. 2014 Feb;218(2):206-17.
  • Hornick JL.Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors.Mod Pathol. 2014 Jan;27 Suppl 1:S47-63.
  • Hornick JL, Mangham DC.Annual review issue: soft tissue tumour pathology.Histopathology. 2014 Jan;64(1):1.
  • Doyle LA, Hornick JL.Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase.Histopathology. 2014 Jan;64(1):53-67.
  • Thum C, Husain EA, Mulholland K, Hornick JL, Brenn T.Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.Ann Diagn Pathol. 2013 Dec;17(6):502-7.
  • Doyle LA, Hornick JL, Fletcher CD.PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters.Am J Surg Pathol. 2013 Dec;37(12):1769-82.
  • Mason EF, Hornick JL.Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.Mod Pathol. 2013 Nov;26(11):1492-7.
  • Kamran SC, Shinagare AB, Howard SA, Nishino M, Hornick JL, Krajewski KM, Ramaiya NH.Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management.Radiol Oncol. 2013;47(3):230-8.
  • Beadling C, Patterson J, Justusson E, Nelson D, Pantaleo MA, Hornick JL, Chacón M, Corless CL, Heinrich MC.Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.Cancer Med. 2013 Feb;2(1):21-31.
  • Doyle LA, Hornick JL.EWSR1 rearrangements in sclerosing epithelioid fibrosarcoma.Am J Surg Pathol. 2013 Oct;37(10):1630-1.
  • Mason EF, Sadow PM, Wagner AJ, Remillard SP, Flood TA, Belanger EC, Hornick JL, Barletta JA.Identification of succinate dehydrogenase-deficient bladder paragangliomas.Am J Surg Pathol. 2013 Oct;37(10):1612-8.
  • Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, Brosjö O, Domanski HA, Larsson O, Sciot R, Debiec-Rychter M, Hornick JL, Mandahl N, Nord KH, Mertens F.Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor.Genes Chromosomes Cancer. 2013 Oct;52(10):873-86.
  • Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, Jung J, Michaud M, Walker BJ, Young S, Earl AM, Kostic AD, Ojesina AI, Hasserjian R, Ballen KK, Chen YB, Hobbs G, Antin JH, Soiffer RJ, Baden LR, Garrett WS, Hornick JL, Marty FM, Meyerson M.Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.N Engl J Med. 2013 Aug 8;369(6):517-28.
  • Adackapara CA, Sholl LM, Barletta JA, Hornick JL.Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.Histopathology. 2013 Aug;63(2):187-93.
  • Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC.Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.PLoS ONE. 2013;8(6):e67306.
  • Conner JR, Hornick JL.SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.Histopathology. 2013 Jul;63(1):36-49.
  • Khandekar MJ, Raut CP, Hornick JL, Wang Q, Alexander BM, Baldini EH.Paratesticular Liposarcoma: Unusual Patterns of Recurrence and Importance of Margins.Ann Surg Oncol. 2013 Apr 17.
  • Jo VY, Antonescu CR, Zhang L, Dal Cin P, Hornick JL, Fletcher CD.Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases.Am J Surg Pathol. 2013 May;37(5):710-8.
  • Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, Ferry JA, Hornick JL.Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.Mod Pathol. 2013 Apr;26(4):533-43.
  • Al-Zaid T, Wang WL, Lopez-Terrada D, Lev D, Hornick JL, Hafeez Diwan A, Fletcher CD, Lazar AJ.Pleomorphic fibroma and dermal atypical lipomatous tumor: are they related?.J Cutan Pathol. 2013 Apr;40(4):379-84.
  • Sholl LM, Weremowicz S, Gray SW, Wong KK, Chirieac LR, Lindeman NI, Hornick JL.Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.J Thorac Oncol. 2013 Mar;8(3):322-8.
  • Hoffman A, Ghadimi MP, Demicco EG, Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D, Hornick JL, Wang WL, Ravi V, Lazar AJ, Lev D, Pollock RE.Localized and metastatic myxoid/round cell liposarcoma: Clinical and molecular observations.Cancer. 2013 Feb 7.
  • Antonescu CR, Romeo S, Zhang L, Nafa K, Hornick JL, Nielsen GP, Mino-Kenudson M, Huang HY, Mosquera JM, Dei Tos PA, Fletcher CD.Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy.Am J Surg Pathol. 2013 Mar;37(3):385-92.
  • Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED, Colombo C, Lam R, Dogan TE, Hornick JL, Lazar AJ, Hunt KK, Anderson ML, Creighton CJ, Lev D, Pollock RE.Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution's Experience.Ann Surg Oncol. 2013 Jan 20.
  • Shinagare AB, Krajewski KM, Hornick JL, Zukotynski K, Kurra V, Jagannathan JP, Ramaiya NH.MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience.AJR Am J Roentgenol. 2012 Dec;199(6):1193-8.
  • Saboo SS, Krajewski KM, Zukotynski K, Howard S, Jagannathan JP, Hornick JL, Ramaiya N.Imaging features of primary and secondary adult rhabdomyosarcoma.AJR Am J Roentgenol. 2012 Dec;199(6):W694-703.
  • Doyle LA, Nelson D, Heinrich MC, Corless CL, Hornick JL.Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study.Histopathology. 2012 Nov;61(5):801-9.
  • McKay KM, Doyle LA, Lazar AJ, Hornick JL.Expression of ERG, an Ets family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics.Histopathology. 2012 Nov;61(5):989-91.
  • Brcic L, Sherer CK, Shuai Y, Hornick JL, Chirieac LR, Dacic S.Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing sox2.Am J Clin Pathol. 2012 Nov;138(5):712-8.
  • Morikawa T, Tanaka N, Kuchiba A, Nosho K, Yamauchi M, Hornick JL, Swanson RS, Chan AT, Meyerhardt JA, Huttenhower C, Schrag D, Fuchs CS, Ogino S.Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies.Arch Surg. 2012 Aug;147(8):715-23.
  • Wang WL, Patel NR, Caragea M, Hogendoorn PC, López-Terrada D, Hornick JL, Lazar AJ.Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma.Mod Pathol. 2012 Oct;25(10):1378-83.
  • Sioletic S, Dal Cin P, Fletcher CD, Hornick JL.Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.Histopathology. 2012 Jun 18.
  • Herfs M, Vargas SO, Yamamoto Y, Howitt BE, Nucci MR, Hornick JL, McKeon FD, Xian W, Crum CP.A novel blueprint for "top down" differentiation defines the cervical squamocolumnar junction during development, reproductive life and neoplasia.J Pathol. 2012 Sep 24.
  • Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL.MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.Am J Surg Pathol. 2012 Oct;36(10):1444-51.
  • Wagner AJ, Remillard SP, Zhang YX, Doyle LA, George S, Hornick JL.Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors.Mod Pathol. 2012 Sep 7.
  • Saboo SS, Krajewski KM, Shinagare AB, Jagannathan JP, Hornick JL, Ramaiya N.Imaging features of primary extranodal histiocytic sarcoma: report of two cases and a review of the literature.Cancer Imaging. 2012;12:253-8.
  • Look Hong NJ, Pandalai PK, Hornick JL, Shekar PS, Harmon DC, Chen YL, Butrynski JE, Baldini EH, Raut CP.Cardiac angiosarcoma management and outcomes: 20-year single-institution experience.Ann Surg Oncol. 2012 Aug;19(8):2707-15.
  • Bakri A, Shinagare AB, Krajewski KM, Howard SA, Jagannathan JP, Hornick JL, Ramaiya NH.Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response.AJR Am J Roentgenol. 2012 Aug;199(2):W208-15. Review.
  • Chen BJ, Mariño-Enríquez A, Fletcher CD, Hornick JL.Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications.Am J Surg Pathol. 2012 Aug;36(8):1119-28.
  • Saab ST, Hornick JL, Fletcher CD, Olson SJ, Coffin CM.IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link?.Mod Pathol. 2011 Apr;24(4):606-12.
  • Doyle LA, Möller E, Cin PD, Fletcher CD, Mertens F, Hornick JL.MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma.Am J Surg Pathol. 2011 Mar 15.
  • Rege TA, Wagner AJ, Corless CL, Heinrich MC, Hornick JL."Pediatric-type" Gastrointestinal Stromal Tumors in Adults: Distinctive Histology Predicts Genotype and Clinical Behavior.Am J Surg Pathol. 2011 Apr;35(4):495-504.
  • Sakharpe A, Lahat G, Gulamhusein T, Liu P, Bolshakov S, Nguyen T, Zhang P, Belousov R, Young E, Xie X, Rao P, Hornick JL, Lazar AJ, Pollock RE, Lev D.Epithelioid Sarcoma and Unclassified Sarcoma with Epithelioid Features: Clinicopathological Variables, Molecular Markers, and a New Experimental Model.Oncologist. 2011 Feb 28.
  • Liang CW, Mariño-Enríquez A, Johannessen C, Hornick JL, Dal Cin P.Translocation (Y;12) in lipoma.Cancer Genet. 2011 Jan;204(1):53-6.
  • Hwang DG, Qian X, Hornick JL.DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks.Am J Clin Pathol. 2011 Mar;135(3):448-53.
  • Hornick JL, Fletcher CD.Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.Am J Surg Pathol. 2011 Feb;35(2):190-201.
  • Shinagare AB, Ramaiya NH, O'Regan K, Jagannathan JP, Hornick JL, Lacasce AS.Helicobacter pylori-Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.J Clin Oncol. 2011 Jan 18.
  • Janeway KA, Kim SY, Lodish M, Nosé V, Rustin P, Gaal J, Dahia PL, Liegl B, Ball ER, Raygada M, Lai AH, Kelly L, Hornick JL, , O'Sullivan M, de Krijger RR, Dinjens WN, Demetri GD, Antonescu CR, Fletcher JA, Helman L, Stratakis CA.Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):314-8.
  • Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL.Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.Am J Surg Pathol. 2011 Jan;35(1):135-44.
  • Coco DP, Goldblum JR, Hornick JL, Lauwers GY, Montgomery E, Srivastava A, Wang H, Odze RD.Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus.Am J Surg Pathol. 2011 Jan;35(1):45-54.
  • Butrynski JE, D'Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark JW, Wilner KD, Christensen JG, Jänne PA, Maki RG, Demetri GD, Shapiro GI.Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.N Engl J Med. 2010 Oct 28;363(18):1727-33.
  • Elco CP, Mariño-Enríquez A, Abraham JA, Dal Cin P, Hornick JL.Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link.Am J Surg Pathol. 2010 Nov;34(11):1723-7.
  • Dorfman DM, Hornick JL, Shahsafaei A, Freeman GJ.The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.Hum Pathol. 2010 Oct;41(10):1486-94.
  • Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL.Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.Am J Surg Pathol. 2010 Aug;34(8):1122-31.
  • Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL.Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.Am J Surg Pathol. 2010 Aug;34(8):1193-8.
  • Long KB, Butrynski JE, Blank SD, Ebrahim KS, Dressel DM, Heinrich MC, Corless CL, Hornick JL.Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.Am J Surg Pathol. 2010 Jun;34(6):907-12.
  • Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, Hirsch MS.PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.Am J Surg Pathol. 2010 May;34(5):627-35.
  • Long KB, Srivastava A, Hirsch MS, Hornick JL.PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.Am J Surg Pathol. 2010 May;34(5):723-9.
  • Mino-Kenudson M, Chirieac LR, Law K, Hornick JL, Lindeman N, Mark EJ, Cohen DW, Johnson BE, Jänne PA, Iafrate AJ, Rodig SJ.A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.Clin Cancer Res. 2010 Mar 1;16(5):1561-71.
  • Hornick JL, Bundock EA, Fletcher CD.Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.Am J Surg Pathol. 2009 Oct;33(10):1554-61.
  • Sholl LM, Long KB, Hornick JL.Sox2 Expression in Pulmonary Non-small Cell and Neuroendocrine Carcinomas.Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):55-61.
  • Coco DP, Hirsch MS, Hornick JL.Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.Am J Surg Pathol. 2009 Dec;33(12):1795-801.
  • Long KB, Hornick JL.SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract.Hum Pathol. 2009 Dec;40(12):1768-73.
  • Brock JE, Hornick JL, Richardson AL, Dillon DA, Lester SC.A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.Am J Clin Pathol. 2009 Sep;132(3):396-401.
  • Boland JM, Folpe AL, Hornick JL, Grogg KL.Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: diagnostic and histogenetic implications.Am J Surg Pathol. 2009 Aug;33(8):1225-9.
  • Baba Y, Nosho K, Shima K, Freed E, Irahara N, Philips J, Meyerhardt JA, Hornick JL, Shivdasani RA, Fuchs CS, Ogino S.Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.Clin Cancer Res. 2009 Jul 15;15(14):4665-73.
  • Yang Q,Hornick JL,Granter SR,Wang LC.Merkel Cell Carcinoma: Lack of KIT Positivity and Implications for the Use of Imatinib Mesylate.Appl Immunohistochem Mol Morphol. 2009 Jul;17(4):276-81. Review.
  • Chang MC,Vargas SO,Hornick JL,Hirsch MS,Crum CP,Nucci MR.Embryonic Stem Cell Transcription Factors and D2-40 (Podoplanin) as Diagnostic Immunohistochemical Markers in Ovarian Germ Cell Tumors.Int J Gynecol Pathol. 2009 Jul;28(4):347-55.
  • Marsee DK,Pinkus GS,Hornick JL.Podoplanin (D2-40) is a Highly Effective Marker of Follicular Dendritic Cells.Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):102-7.
  • Wang WL,Hornick JL,Mallipeddi R,Zelger BG,Rother JD,Yang D,Lev DC,Trent JC,Prieto VG,Brenn T,Calonje E,Lazar AJ.Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: a series of 5 cases with molecular analysis.Am J Dermatopathol. 2009 May;31(3):297-300.
  • Liegl B,Hornick JL,Lazar AJ.Contemporary pathology of gastrointestinal stromal tumors.Hematol Oncol Clin North Am. 2009 Feb;23(1):49-68, vii-viii.
  • Permaul P,Narla A,Hornick JL,Pai SY.Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes.Immunol Res. 2009;44(1-3):89-98. Review.
  • Wang VS,Hornick JL,Sepulveda JA,Mauer R,Poneros JM.Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.Gastrointest Endosc. 2009 Apr;69(4):777-83.
  • Kulke MH,Hornick JL,Frauenhoffer C,Hooshmand S,Ryan DP,Enzinger PC,Meyerhardt JA,Clark JW,Stuart K,Fuchs CS,Redston MS.O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.Clin Cancer Res. 2009 Jan 1;15(1):338-45.
  • Gibson JA,Hornick JL.Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas.Am J Surg Pathol. 2009 May;33(5):781-7.
  • Srivastava A,Hornick JL.Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.Am J Surg Pathol. 2009 Apr;33(4):626-32.
  • Hornick JL,Dal Cin P,Fletcher CD.Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.Am J Surg Pathol. 2009 Apr;33(4):542-50.
  • Liegl B,Hornick JL,Corless CL,Fletcher CD.Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.Am J Surg Pathol. 2009 Mar;33(3):437-46.
  • Liegl B,Hornick JL,Antonescu CR,Corless CL,Fletcher CD.Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.Am J Surg Pathol. 2009 Feb;33(2):218-26.
  • Bracht LK,Wen P,Meyerhardt JA,Kulke MH,Hornick JL,Redston M,LaFrankie DC,Black PM,Kesari S,Norden A,Drappatz J.DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.J Clin Oncol. 2008 Oct 10;26(29):4843-4.
  • Gasparotto D,Rossi S,Bearzi I,Doglioni C,Marzotto A,Hornick JL,Grizzo A,Sartor C,Mandolesi A,Sciot R,Debiec-Rychter M,Dei Tos AP,Maestro R.Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity.Clin Cancer Res. 2008 Sep 15;14(18):5715-21.
  • Liegl B, Hornick JL, Fletcher CD.Primary Cutaneous PEComa: Distinctive Clear Cell Lesions of Skin.Am J Surg Pathol. 2008 Apr;32(4):608-14.
  • Hornick JL, Fletcher CD.Sclerosing PEComa: Clinicopathologic Analysis of a Distinctive Variant With a Predilection for the Retroperitoneum.Am J Surg Pathol. 2008 Apr;32(4):493-501.
  • Hollmann TJ, Brenn T, Hornick JL.CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.Am J Surg Pathol. 2008 Jan;32(1):139-45.
  • Hornick JL, Mino-Kenudson M, Lauwers GY, Liu W, Goyal R, Odze RD.Buried Barrett's Epithelium Following Photodynamic Therapy Shows Reduced Crypt Proliferation and Absence of DNA Content Abnormalities.Am J Gastroenterol. 2008 Jan;103(1):38-47.
  • Hahn HP, Hornick JL.Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.Am J Surg Pathol. 2007 Nov;31(11):1669-76.
  • Hornick JL, Odze RD.Neoplastic precursor lesions in Barrett's esophagus.Gastroenterol Clin North Am. 2007 Dec;36(4):775-96, v. Review.
  • Yu H, Pinkus GS, Hornick JL.Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.Am J Clin Pathol. 2007 Nov;128(5):767-75.
  • Yu H, Gibson JA, Pinkus GS, Hornick JL.Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.Am J Clin Pathol. 2007 Nov;128(5):776-82.
  • Gleason BC, Hornick JL.Inflammatory myofibroblastic tumours: where are we now?.J Clin Pathol. 2008 Apr;61(4):428-37. Review.
  • Ito H, Hornick JL, Bertagnolli MM, George S, Morgan JA, Baldini EH, Wagner AJ, Demetri GD, Raut CP.Leiomyosarcoma of the inferior vena cava: survival after aggressive management.Ann Surg Oncol. 2007 Dec;14(12):3534-41.
  • Santagata S, Ligon KL, Hornick JL.Embryonic Stem Cell Transcription Factor Signatures in the Diagnosis of Primary and Metastatic Germ Cell Tumors.Am J Surg Pathol. 2007 Jun;31(6):836-845.
  • Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF.Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.Am J Surg Pathol. 2007 Jun;31(6):947-52.
  • Hornick JL, Fletcher CD.The role of KIT in the management of patients with gastrointestinal stromal tumors.Hum Pathol. 2007 May;38(5):679-87. Review.
  • Coffin CM, Hornick JL, Fletcher CD.Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.Am J Surg Pathol. 2007 Apr;31(4):509-20.
  • Srivastava A, Hornick JL, Li X, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD.Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.Am J Gastroenterol. 2007 Mar;102(3):483-93; quiz 694.
  • Hornick JL, Farraye FA, Odze RD.Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.Am J Surg Pathol. 2007 Feb;31(2):207-15.
  • Carrasco DR, Fenton T, Sukhdeo K, Protopopova M, Enos M, You MJ, Divicio D, Nogueira C, Stommel J, Pinkus GS, Fletcher C, Hornick JL, Cavenee WK, Furnari FB, Depinho RA.The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans.Cancer Cell. 2006 May;9(5):379-90.
  • Carter MR, Hornick JL, Lester S, Fletcher CD.Spindle Cell (Sarcomatoid) Carcinoma of the Breast: A Clinicopathologic and Immunohistochemical Analysis of 29 Cases.Am J Surg Pathol. 2006 Mar;30(3):300-309.
  • Hornick JL, Fletcher CD.Intraarticular nodular fasciitis--a rare lesion: clinicopathologic analysis of a series.Am J Surg Pathol. 2006 Feb;30(2):237-41.
  • Hahn HP, Bundock EA, Hornick JL.Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics.Am J Clin Pathol. 2006 Feb;125(2):203-8.
  • Hornick JL, Fletcher CD.PEComa: what do we know so far?.Histopathology. 2006 Jan;48(1):75-82.
  • Hornick JL, Farraye FA, Odze RD.Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma.Am J Surg Pathol. 2006 Jan;30(1):28-35.
  • George S, Hornick JL, Bertagnolli MM, Fletcher CD, Demetri GD.Current management of metastatic gastrointestinal stromal tumor: a case report.Clin Adv Hematol Oncol. 2003 Jan;1(1):63-4; discussion 65.
  • Hornick JL, Fletcher CD.Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases.Am J Surg Pathol. 2005 Jul;29(7):859-65.
  • Hornick JL, Fletcher CD.Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features.Am J Surg Pathol. 2005 Jul;29(7):845-58.
  • Hornick JL, Fletcher CD.Intraabdominal cystic lymphangiomas obscured by marked superimposed reactive changes: clinicopathological analysis of a series.Hum Pathol. 2005 Apr;36(4):426-32.
  • Hornick JL, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD.Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.Am J Surg Pathol. 2005 Mar;29(3):372-80.
  • Hornick JL, Lauwers GY, Odze RD.Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.Am J Surg Pathol. 2005 Mar;29(3):381-9.
  • Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CD.Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases.Am J Surg Pathol. 2004 Oct;28(10):1257-67.
  • Hornick JL, Jaffe ES, Fletcher CD.Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.Am J Surg Pathol. 2004 Sep;28(9):1133-44.
  • Mutinga ML, Odze RD, Wang HH, Hornick JL, Farraye FA.The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis.Inflamm Bowel Dis. 2004 May;10(3):215-9.
  • Duensing A, Joseph NE, Medeiros F, Smith F, Hornick JL, Heinrich MC, Corless CL, Demetri GD, Fletcher CD, Fletcher JA.Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs).Cancer Res. 2004 Aug 1;64(15):5127-31.
  • Odze RD, Farraye FA, Hecht JL, Hornick JL.Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis.Clin Gastroenterol Hepatol. 2004 Jul;2(7):534-41.
  • Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD.KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.Am J Surg Pathol. 2004 Jul;28(7):889-94.
  • Hornick JL, Fletcher CD.The significance of KIT (CD117) in gastrointestinal stromal tumors.Int J Surg Pathol. 2004 Apr;12(2):93-7.
  • Hornick JL, Fletcher CD.Cutaneous myoepithelioma: a clinicopathologic and immunohistochemical study of 14 cases.Hum Pathol. 2004 Jan;35(1):14-24.
  • Hornick JL, Fletcher CD.Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.Am J Surg Pathol. 2003 Sep;27(9):1183-96.
  • Hornick JL, Fletcher CD.Validating immunohistochemical staining for KIT (CD117).Am J Clin Pathol. 2003 Mar;119(3):325-7.
  • Hornick JL, Fletcher CD.Criteria for malignancy in nonvisceral smooth muscle tumors.Ann Diagn Pathol. 2003 Feb;7(1):60-6.
  • Nascimento AF, Ruiz R, Hornick JL, Fletcher CD.Calcifying fibrous 'pseudotumor': clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor.Int J Surg Pathol. 2002 Jul;10(3):189-96.
  • Hornick JL, Fletcher CD.Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.Am J Clin Pathol. 2002 Feb;117(2):188-93.
  • Hornick JL, Sharifi J, Khawli LA, Hu P, Biela BH, Mizokami MM, Yun A, Taylor CR, Epstein AL.A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors.Cancer Biother Radiopharm. 1998 Aug;13(4):255-68.
  • Hornick JL, Sharifi J, Khawli LA, Hu P, Bai WG, Alauddin MM, Mizokami MM, Epstein AL.Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.J Nucl Med. 2000 Feb;41(2):355-62.
  • Sharifi J, Khawli LA, Hornick JL, Epstein AL.Improving monoclonal antibody pharmacokinetics via chemical modification.Q J Nucl Med. 1998 Dec;42(4):242-9.
  • Hornick JL, Khawli LA, Hu P, Sharifi J, Khanna C, Epstein AL.Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors.Clin Cancer Res. 1999 Jan;5(1):51-60.
  • Funakoshi S, Hirano A, Beckwith M, Asai O, Jorgensen G, Tian Z, Hornick JL, Hu P, Khawli LA, Epstein AL, Longo DL, Murphy WJ.Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo.Blood. 1997 Oct 15;90(8):3160-6.
  • Hornick JL, Khawli LA, Hu P, Lynch M, Anderson PM, Epstein AL.Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.Blood. 1997 Jun 15;89(12):4437-47.
  • Hu P, Hornick JL, Glasky MS, Yun A, Milkie MN, Khawli LA, Anderson PM, Epstein AL.A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptake.Cancer Res. 1996 Nov 1;56(21):4998-5004.
  • Epstein AL, Khawli LA, Hornick JL, Taylor CR.Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.Cancer Res. 1995 Jun 15;55(12):2673-80.
  • Hu P, Glasky MS, Yun A, Alauddin MM, Hornick JL, Khawli LA, Epstein AL.A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.Hum Antibodies Hybridomas. 1995;6(2):57-67.
  • Akileswaran L, Alic M, Clark EK, Hornick JL, Gold MH.Isolation and transformation of uracil auxotrophs of the lignin-degrading basidiomycete Phanerochaete chrysosporium.Curr Genet. 1993;23(4):351-6.